ClinicalTrials.Veeva

Menu

Th17 Inducing Cytokines Pregnancy and After Postpartum

A

Aydin Adnan Menderes University

Status

Completed

Conditions

Pregnancy

Treatments

Other: Saliva collection
Other: GCF collection

Study type

Observational

Funder types

Other

Identifiers

NCT03449186
BAP-2015

Details and patient eligibility

About

The aim of this study was to investigate salivary and gingival crevicular fluid (GCF) levels of IL-17A, IL-17E, IL-6 AND IL-23 during 2/3 trimester of pregnancy and after delivery.

Full description

IL-17 have a synergytic effect with IL-6 and IL-23. IL-17A levels elevated with periodontal diseases. Many systemical chronic conditions such as atherosclerosis and cardiovascular disease, pregnancy may contribute increasing of IL-17 family cytokine.

Enrollment

114 patients

Sex

Female

Ages

19 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women 2 and 3 trimester of their pregnancy

Exclusion criteria

  • any known systemic disease,
  • periodontal treatment within the last six months,
  • patients having less than 10 teeth,
  • smokers,
  • individuals with a BMI > 30 kg/m2,
  • gestational diabetes and preeclampsia during pregnancy.

Trial design

114 participants in 2 patient groups

Pregnancy group
Description:
Women, who were in their second trimester (weeks 16-24) or third trimester (weeks 25-34)selected for the study. Saliva and GCF samples were collected and clinical periodontal measurements were made gently
Treatment:
Other: Saliva collection
Other: GCF collection
Postpartum group
Description:
Postpartum women 6 months after giving birth recalled. Saliva and GCF samples were collected and clinical periodontal measurements were made.
Treatment:
Other: Saliva collection
Other: GCF collection

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems